Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.607 USD | +5.93% | +4.82% | -33.49% |
Business Summary
Number of employees: 135
Managers
Managers | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 18-05-06 |
Chief Tech/Sci/R&D Officer | - | 23-10-02 | |
Richard Aranda
CTO | Chief Tech/Sci/R&D Officer | 64 | 18-01-31 |
Christian Waage
ADM | Chief Administrative Officer | 57 | 17-07-31 |
Bob Smith
PRN | Corporate Officer/Principal | 55 | Dec. 04 |
Jeff Boerneke
LAW | General Counsel | - | 20-12-31 |
Deanna Weber
HRO | Human Resources Officer | - | 18-03-31 |
Caryn Peterson
LAW | General Counsel | 65 | 17-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Thomas Daniel
BRD | Director/Board Member | 70 | 17-12-31 |
Skye Drynan
BRD | Director/Board Member | 48 | Mar. 10 |
John Quisel
BRD | Director/Board Member | 52 | Nov. 27 |
Russell Cox
BRD | Director/Board Member | 60 | 18-12-18 |
Sandra Milligan
BRD | Director/Board Member | 60 | 21-06-09 |
Steven Nathan
BRD | Director/Board Member | 65 | Mar. 10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 226,218,652 | 219,535,762 ( 97.05 %) | 0 | 97.05 % |
Company contact information
Gossamer Bio, Inc.
3013 Science Park Road Suite 200
92121, San Diego
+858 684 1300
http://www.gossamerbio.comGroup companies
Name | Category and Sector |
---|---|
Gossamer Bio Services, Inc.
Gossamer Bio Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Gossamer Bio, Inc., Gossamer Bio Services, Inc. operates as an American biopharmaceutical company which discovers, develops and commercializes immunology-based therapeutics. The company is located in the US. |
Pharmaceuticals: Major
|
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.49% | 130M | |
+57.17% | 59.34B | |
+43.17% | 40.24B | |
-5.09% | 39.88B | |
-5.56% | 28.55B | |
+14.66% | 27.26B | |
-21.46% | 19.23B | |
+32.16% | 12.61B | |
+1.96% | 12.49B | |
+25.50% | 12.28B |
- Stock Market
- Equities
- GOSS Stock
- Company Gossamer Bio, Inc.